Paragraph 7
F1In relation to Great Britain, directions shall be given—
for the purpose of securing that procurement organisations comply with the requirements of the Annex to the first Directive (information to be provided on the donation of tissue or cells), and
for the purpose of securing that procurement organisations and organisations responsible for human application of tissue or cells comply with F2the requirements of these Regulations in relation to notification of serious adverse reactions and notification of serious adverse events.
Annotations
Textual amendments
- F1
Words in Sch. 2 para. 7 substituted (31.12.2020) by The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(21)(d)(i) (as substituted by S.I. 2020/1306, regs. 1, 25(f)); 2020 c. 1, Sch. 5 para. 1(1)
- F2
Words in Sch. 2 para. 7(b) substituted (31.12.2020) by The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(21)(d)(ii) (as substituted by S.I. 2020/1306, regs. 1, 25(f)); 2020 c. 1, Sch. 5 para. 1(1)
Notes on Schedule 2
Textual amendments
- F1
Sch. 2 restricted (temp.) (31.12.2020) by The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 4 (as amended by S.I. 2020/1306, regs. 1, 26(b)); 2020 c. 1, Sch. 5 para. 1(1)
- F2
Sch. 2 heading substituted (6.3.2018 for specified purposes, 1.4.2018 in so far as not already in force) by The Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2018 (S.I. 2018/335), regs. 1(2)(3), 8(1)(a)